BioIntelliSense
PrivateLast Round
Series B
Jun 4, 2026
Total Funding Raised
$84.8M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
BioIntelliSense is a health technology company that provides a medical-grade Data-as-a-Service (DaaS) platform for continuous remote patient monitoring and clinical intelligence.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Telemedicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioIntelliSense Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
BioIntelliSense Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 4, 2026 | ||||
| Series C | Dec 1, 2025 | ||||
| Series B | Jul 28, 2021 | ||||
| Grant | Dec 22, 2020 | ||||
| Series A Extension | Sep 8, 2020 | ||||
Series A | Jul 9, 2019 |
Key People
Founding team and executive leadership
BioIntelliSense Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 7wire Ventures | Series B |
| Chimera Investment LLC | Series B |
| TripleTree | Series A, Series B |
| U.S. Department of War | Grant |
| Fresenius Medical Care North America | Series A, Series B |
| Pendrell Corporation | Series B |
| Chimera Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2026
$58.3M raised in Series B funding.
- Jan 24, 2026
Solution implemented for Alaska's Rural Health Transformation Program.
BioIntelliSense Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioIntelliSense's valuation, stock price, and market status.